Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids

Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids

Jon Andsnes Berg,1 Jan Schjøtt,1,2 Kjell O Fossan,1 Bettina Riedel1,21Section of Clinical Pharmacology, Laboratory of Clinical Biochemistry, Haukeland University Hospital, 2Faculty of Medicine and Dentistry, Department of Clinical Science, University of Bergen, Bergen, NorwayPurpose: The...

Full description

Bibliographic Details
Main Authors:	Berg JA, Schjøtt J, Fossan KO, Riedel B
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-10-01
Series:	Substance Abuse and Rehabilitation
Online Access:	https://www.dovepress.com/cross-reactivity-of-the-cedia-buprenorphine-assay-in-drugs-of-abuse-sc-peer-reviewed-article-SAR

Similar Items

Single high-dose buprenorphine for opioid craving during withdrawal
by: Jamshid Ahmadi, et al.
Published: (2018-12-01)

Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
by: Webster LR, et al.
Published: (2015-11-01)

Successful Treatment of Opioid Dependence with Flexible Doses of Injectable Prolonged Release Buprenorphine
by: Oscar D’Agnone
Published: (2019-01-01)

Advances in the delivery of buprenorphine for opioid dependence
by: Rosenthal RN, et al.
Published: (2017-08-01)

Analogues of buprenorphine as treatment for opioid dependence
by: Grivas, Konstantinos
Published: (1995)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
by: Florence Noble, et al.
Published: (2019-01-01)

Counseling interventions with buprenorphine for treatment of opioid use disorders
by: Ripley, Dana Marie
Published: (2019)

Hallucination with Tapering Dose of Buprenorphine
by: Poonam Bharti, et al.
Published: (2020-03-01)

Opioid substitution treatment using buprenorphine for management of dependence on natural opioids: Case series
by: Preethy Kathiresan, et al.
Published: (2019-01-01)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
by: Ingunn O. Lund, et al.
Published: (2013-03-01)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
by: Ingunn O. Lund, et al.
Published: (2013-01-01)

Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic Pain
by: Pergolizzi Jr JV, et al.
Published: (2019-12-01)

Does buprenorphine maintenance improve the quality of life of opioid users?
by: A Dhawan, et al.
Published: (2013-01-01)

Management of opioid addiction with buprenorphine: French history and current management
by: Poloméni P, et al.
Published: (2014-03-01)

Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder
by: Ruihua Dong, et al.
Published: (2019-06-01)

Comment on "A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes"
by: Robert G. Newman, et al.
Published: (2013-05-01)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes”
by: Robert G. Newman M.D., M.P.H., et al.
Published: (2013-01-01)

Cocaine use, treatment retention and opioid abstinence at six months in a coordinated primary care and substance abuse treatment clinic among opioid-dependent patients treated with buprenorphine
by: Culp, Jenna L.
Published: (2015)

Opioid withdrawal presenting as delirium and role of buprenorphine: A case series
by: Sourav Das, et al.
Published: (2017-01-01)

Methadone or buprenorphine? The choice of substitution therapy in pregnant opioid dependent women
by: Jadwiga Zalewska-Kaszubska
Published: (2019-01-01)

Buprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain
by: Khanna IK, et al.
Published: (2015-12-01)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
by: Mauger S, et al.
Published: (2014-04-01)

Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals
by: Webster LR, et al.
Published: (2016-06-01)

Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management
by: Anderson, B.J, et al.
Published: (2018)

Buprenorphine as an Efficacious Treatment for Opioid Dependency? A Survey of Counselors Attitudes
by: Agnew, Carol J.
Published: (2011)

Predictors of Neonatal Abstinence Syndrome in Buprenorphine Exposed Newborn: Can Cord Blood Buprenorphine Metabolite Levels Help?
by: Shah, Darshan, et al.
Published: (2016)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
by: Niraj R. Chavan, et al.
Published: (2017-10-01)

Case Series of Patients with Opioid Use Disorder and Suicidal Ideation Treated with Buprenorphine
by: Max Spaderna, et al.
Published: (2021-02-01)

Comparison of Sleep Problems in Opioid-Dependent Patients under Methadone and Buprenorphine Treatment
by: Mehdi Madanifard, et al.
Published: (2018-02-01)

Buprenorphine for Opioid Use Disorder in the Emergency Department: A Retrospective Chart Review
by: Kathy T. LeSaint, et al.
Published: (2020-08-01)

Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation
by: Ling W, et al.
Published: (2019-11-01)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
by: Soyka M
Published: (2015-01-01)

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation
by: M Connock, et al.
Published: (2007-03-01)

Predictors of Dropout from Inpatient Opioid Detoxification with Buprenorphine: A Chart Review
by: Anders Hakansson, et al.
Published: (2014-01-01)

Buprenorphine Transdermal System for Opioid Therapy in Patients with Chronic Low Back Pain
by: Allan Gordon, et al.
Published: (2010-01-01)

New developments in managing opioid addiction: impact of a subdermal buprenorphine implant
by: Itzoe M, et al.
Published: (2017-05-01)

A review of opioid replacement therapy with methadone or buprenorphine on neural development in the newborn
by: Javaid, Maham
Published: (2016)

Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
by: Justin C Yang, et al.
Published: (2020-01-01)

Transdermal delivery of a buprenorphine/naltrexone combination for the treatment of polydrug abuse
by: Cordery, Sarah F.
Published: (2016)

Current status and views of Methadone and Buprenorphine/Naloxone Maintenance Treatment in Patients with Opioid-Addiction
by: YA-LI LIANG, et al.
Published: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r76qgjtsjo0c94nffnffv7c551